Sequent Scientific Limited (SEQUENT.NS)
INR 143.21
(-0.62%)
INR 143.21
(-0.62%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.9 Billion INR | -52.75% |
| 2022 | 6.14 Billion INR | 23.34% |
| 2021 | 4.97 Billion INR | 14.51% |
| 2020 | 4.34 Billion INR | 13.31% |
| 2019 | 3.83 Billion INR | 11.87% |
| 2018 | 3.43 Billion INR | 15.01% |
| 2017 | 2.98 Billion INR | -16.32% |
| 2016 | 3.56 Billion INR | 43.38% |
| 2015 | 2.48 Billion INR | 38.28% |
| 2014 | 1.79 Billion INR | 9.79% |
| 2013 | 1.63 Billion INR | 21.22% |
| 2012 | 1.35 Billion INR | 4.55% |
| 2011 | 1.29 Billion INR | 9.35% |
| 2010 | 1.18 Billion INR | 23.54% |
| 2009 | 956.4 Million INR | 12.43% |
| 2008 | 850.65 Million INR | 500.94% |
| 2007 | 141.55 Million INR | 384.76% |
| 2006 | 29.2 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 711.4 Million INR | -11.63% |
| 2023 FY | 2.9 Billion INR | -52.75% |
| 2023 Q2 | 1.53 Billion INR | -2.64% |
| 2023 Q1 | 1.58 Billion INR | 0.47% |
| 2023 Q4 | 702.13 Million INR | 3.29% |
| 2023 Q3 | 679.76 Million INR | -55.85% |
| 2022 Q4 | 1.57 Billion INR | 0.01% |
| 2022 Q3 | 1.57 Billion INR | 7.14% |
| 2022 Q1 | 1.51 Billion INR | 87.83% |
| 2022 Q2 | 1.46 Billion INR | -2.75% |
| 2022 FY | 6.14 Billion INR | 23.34% |
| 2021 Q1 | 1.46 Billion INR | 97.12% |
| 2021 FY | 4.97 Billion INR | 14.51% |
| 2021 Q4 | 804.2 Million INR | -36.75% |
| 2021 Q3 | 1.27 Billion INR | -11.5% |
| 2021 Q2 | 1.43 Billion INR | -2.03% |
| 2020 Q3 | 1.25 Billion INR | -0.41% |
| 2020 Q2 | 1.25 Billion INR | 11.28% |
| 2020 Q1 | 1.12 Billion INR | 131.46% |
| 2020 FY | 4.34 Billion INR | 13.31% |
| 2020 Q4 | 743.99 Million INR | -40.51% |
| 2019 FY | 3.83 Billion INR | 11.87% |
| 2019 Q3 | 1.17 Billion INR | 8.23% |
| 2019 Q4 | 487.53 Million INR | -58.59% |
| 2019 Q1 | 1.08 Billion INR | 175.5% |
| 2019 Q2 | 1.08 Billion INR | 0.27% |
| 2018 Q4 | 393.73 Million INR | -62.41% |
| 2018 FY | 3.43 Billion INR | 15.01% |
| 2018 Q3 | 1.04 Billion INR | 1.57% |
| 2018 Q2 | 1.03 Billion INR | 7.69% |
| 2018 Q1 | 957.63 Million INR | 67.97% |
| 2017 Q3 | 955.07 Million INR | -9.67% |
| 2017 Q2 | 1.05 Billion INR | 0.66% |
| 2017 Q1 | 1.05 Billion INR | -15.67% |
| 2017 FY | 2.98 Billion INR | -16.32% |
| 2017 Q4 | 570.12 Million INR | -40.31% |
| 2016 Q1 | 930.24 Million INR | 102.13% |
| 2016 Q4 | 1.24 Billion INR | 28.92% |
| 2016 Q3 | 966.24 Million INR | -16.55% |
| 2016 FY | 3.56 Billion INR | 43.38% |
| 2016 Q2 | 1.15 Billion INR | 24.47% |
| 2015 Q3 | 744.05 Million INR | 8.07% |
| 2015 Q2 | 688.47 Million INR | 18.64% |
| 2015 FY | 2.48 Billion INR | 38.28% |
| 2015 Q1 | 580.31 Million INR | 265.41% |
| 2015 Q4 | 460.21 Million INR | -38.15% |
| 2014 Q3 | 579.91 Million INR | -0.34% |
| 2014 Q2 | 581.87 Million INR | 22.03% |
| 2014 Q1 | 476.82 Million INR | 2269.88% |
| 2014 FY | 1.79 Billion INR | 9.79% |
| 2014 Q4 | 158.81 Million INR | -72.61% |
| 2013 Q3 | 518.13 Million INR | -11.79% |
| 2013 Q4 | 20.12 Million INR | -96.12% |
| 2013 FY | 1.63 Billion INR | 21.22% |
| 2013 Q1 | 527.53 Million INR | 156.47% |
| 2013 Q2 | 587.4 Million INR | 11.35% |
| 2012 FY | 1.35 Billion INR | 4.55% |
| 2012 Q4 | 205.69 Million INR | -52.65% |
| 2012 Q3 | 434.43 Million INR | 47.71% |
| 2012 Q2 | 294.12 Million INR | -29.38% |
| 2012 Q1 | 416.5 Million INR | 0.0% |
| 2011 FY | 1.29 Billion INR | 9.35% |
| 2010 FY | 1.18 Billion INR | 23.54% |
| 2009 FY | 956.4 Million INR | 12.43% |
| 2008 FY | 850.65 Million INR | 500.94% |
| 2007 FY | 141.55 Million INR | 384.76% |
| 2006 FY | 29.2 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sigachi Industries Limited | 579.88 Million INR | -400.41% |
| Ind-Swift Limited | 946.56 Million INR | -206.562% |
| Innova Captab Limited | 931.03 Million INR | -211.677% |
| Aarti Drugs Limited | 1.16 Billion INR | -148.554% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | 5.614% |
| Bajaj HealthCare Limited | 985.34 Million INR | -194.497% |
| Sakar Healthcare Limited | 204.07 Million INR | -1321.905% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 94.786% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -13.614% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -17.316% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -1688.723% |
| Morepen Laboratories Limited | 1.98 Billion INR | -46.007% |
| Wanbury Limited | 978.96 Million INR | -196.416% |
| Laurus Labs Limited | 11.9 Billion INR | 75.635% |
| Nectar Lifesciences Limited | 932.7 Million INR | -211.119% |
| Gufic Biosciences Limited | 1.18 Billion INR | -144.551% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 75.072% |
| Alembic Limited | 872.45 Million INR | -232.602% |
| Hikal Limited | 4.46 Billion INR | 34.992% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 81.715% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 93.82% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -31.841% |
| Themis Medicare Limited | 1.12 Billion INR | -157.756% |
| RPG Life Sciences Limited | 1.63 Billion INR | -77.426% |
| Lupin Limited | 125.09 Billion INR | 97.68% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -38.575% |
| Wockhardt Limited | 8.48 Billion INR | 65.781% |
| Vaishali Pharma Limited | 84.02 Million INR | -3353.343% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -561.683% |
| NATCO Pharma Limited | 10.05 Billion INR | 71.149% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 79.924% |
| FDC Limited | 3.49 Billion INR | 17.085% |
| Divi's Laboratories Limited | 14.17 Billion INR | 79.521% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -603.594% |
| Eris Lifesciences Limited | 4.94 Billion INR | 41.294% |
| Windlas Biotech Limited | 1 Billion INR | -188.304% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.118% |
| Mankind Pharma Limited | 29.27 Billion INR | 90.087% |
| Venus Remedies Limited | 1.91 Billion INR | -51.429% |
| ZIM Laboratories Limited | 1.01 Billion INR | -186.441% |
| Neuland Laboratories Limited | 2.92 Billion INR | 0.954% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 80.383% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -170.14% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 97.682% |
| Bal Pharma Limited | 555.62 Million INR | -422.26% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 96.973% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -4878.399% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -33.447% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -104.465% |
| Shilpa Medicare Limited | 3.33 Billion INR | 12.968% |
| Orchid Pharma Limited | 800.77 Million INR | -262.377% |
| Albert David Limited | 1.02 Billion INR | -182.787% |
| Ajanta Pharma Limited | 30.46 Billion INR | 90.474% |
| Hester Biosciences Limited | 908.84 Million INR | -219.287% |
| Valiant Laboratories Limited | 138.02 Million INR | -2002.319% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -106.86% |
| Procter & Gamble Health Limited | 2.99 Billion INR | 3.124% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -20316.59% |
| Granules India Limited | 10.31 Billion INR | 71.862% |
| Alkem Laboratories Limited | 32.83 Billion INR | 91.162% |
| Medicamen Biotech Limited | 335.16 Million INR | -765.78% |
| Unichem Laboratories Limited | 6.72 Billion INR | 56.856% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -536.942% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -42448.534% |
| Medico Remedies Limited | 59.67 Million INR | -4762.69% |
| Ipca Laboratories Limited | 18.98 Billion INR | 84.717% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -739.564% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -36.608% |
| Brooks Laboratories Limited | 51.18 Million INR | -5569.812% |
| Piramal Enterprises Limited | 63.65 Billion INR | 95.441% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 86.454% |
| Suven Life Sciences Limited | 109.75 Million INR | -2544.018% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -6186.962% |
| Strides Pharma Science Limited | 9.16 Billion INR | 68.329% |
| Indoco Remedies Limited | 12.06 Billion INR | 75.941% |
| Alpa Laboratories Limited | 127.38 Million INR | -2178.073% |
| Lasa Supergenerics Limited | 291.17 Million INR | -896.59% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 5.687% |